And what are you looking forward to coming up? Are there any big talks or anything that you’re excited about?
Oh, I used to lead something called the Risk-sharing Scheme, which you guys may have heard of, which is the sort of long-term scheme that got at least reasonable availability of therapies here in the UK, and that’s presenting its ten year results tomorrow, so I’m quite pleased to see that’s eventually reached its ending and that’s probably achieved what we wanted it to do, which means that people with MS in the UK can generally get reasonable access to therapies. May not prescribe the same way as where I now work, but at least there’s a reasonably equitable access, and that’s important.
Mike tells us about the talks at ECTRIMS 2016 that are exciting him the most